Back to top
more

Abbott Laboratories (ABT)

(Delayed Data from NYSE)

$132.37 USD

132.37
4,905,317

-0.05 (-0.04%)

Updated Dec 8, 2021 04:02 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.42%
2Buy19.05%
3Hold10.68%
4Sell6.41%
5Strong Sell3.08%
S&P50011.42%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 27% (183 out of 252)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Research for ABT

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

Fiscal Year End for Abbott Laboratories falls in the month of December.

All items in Millions except Per Share data.

12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Assets          
Cash & Equivalents 7,148 4,140 4,086 9,610 18,775
Receivables 6,414 5,425 5,182 5,249 3,248
Notes Receivable 0 0 0 0 0
Inventories 5,012 4,316 3,796 3,601 2,434
Other Current Assets 1,867 1,786 1,568 1,687 2,319
Total Current Assets 20,441 15,667 14,632 20,147 26,776
Net Property & Equipment 9,029 8,038 7,563 7,607 5,705
Investments & Advances 821 883 897 883 2,947
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 3,729 3,079 1,868 1,944 2,263
Intangibles 38,528 40,220 42,196 45,493 12,222
Deposits & Other Assets 0 0 17 176 2,753
Total Assets 72,548 67,887 67,173 76,250 52,666
Liabilities & Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Notes Payable 213 201 200 206 1,322
Accounts Payable 3,946 3,252 2,975 2,402 1,178
Current Portion Long-Term Debt 7 1,277 7 508 3
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 6,581 5,272 4,962 4,998 3,333
Income Taxes Payable 362 226 305 309 188
Other Current Liabilities 798 635 563 489 636
Total Current Liabilities 11,907 10,863 9,012 8,912 6,660
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 18,527 16,661 19,359 27,210 20,681
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 9,111 9,062 8,080 9,030 4,608
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 39,545 36,586 36,451 45,152 31,949
Shareholders Equity 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016
Preferred Stock 0 0 0 0 0
Common Stock (Par) 24,145 23,853 23,512 23,206 13,027
Capital Surplus 0 0 0 0 0
Retained Earnings 27,627 25,847 24,560 23,978 25,565
Other Equity -8,727 -8,252 -7,388 -5,861 -7,084
Treasury Stock 10,042 10,147 9,962 10,225 10,791
Total Shareholder's Equity 33,003 31,301 30,722 31,098 20,717
Total Liabilities & Shareholder's Equity 72,548 67,887 67,173 76,250 52,666
Total Common Equity 33,003 31,301 30,722 31,098 20,717
Shares Outstanding 1,772.30 1,768.40 1,756.30 1,740.60 1,721.10
Book Value Per Share 18.62 17.70 17.49 17.87 12.04

Fiscal Year End for Abbott Laboratories falls in the month of December.

All items in Millions except Per Share data.

9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020
Assets          
Cash & Equivalents 9,692 8,944 8,372 7,148 4,731
Receivables 6,405 6,113 6,096 6,414 5,649
Notes Receivable 0 0 0 0 0
Inventories 5,261 5,439 5,387 5,012 5,152
Other Current Assets 2,134 2,131 1,962 1,867 1,858
Total Current Assets 23,492 22,627 21,817 20,441 17,390
Net Property & Equipment 8,831 8,816 8,832 9,029 8,620
Investments & Advances 812 805 832 821 803
Other Non-Current Assets 0 0 0 0 0
Deferred Charges 4,049 3,855 3,739 3,729 3,684
Intangibles 36,611 37,166 37,565 38,528 38,546
Deposits & Other Assets 0 0 0 0 0
Total Assets 73,795 73,269 72,785 72,548 69,043
Liabilities & Shareholders Equity 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020
Notes Payable 197 199 199 213 208
Accounts Payable 4,017 4,017 4,066 3,946 3,189
Current Portion Long-Term Debt 754 755 756 7 6
Current Portion Capital Leases 0 0 0 0 0
Accrued Expenses 6,734 6,602 6,364 6,581 6,098
Income Taxes Payable 368 242 276 362 117
Other Current Liabilities 797 799 801 798 639
Total Current Liabilities 12,867 12,614 12,462 11,907 10,257
Mortgages 0 0 0 0 0
Deferred Taxes/Income 0 0 0 0 0
Convertible Debt 0 0 0 0 0
Long-Term Debt 17,446 17,547 17,489 18,527 18,349
Non-Current Capital Leases 0 0 0 0 0
Other Non-Current Liabilities 8,844 9,046 9,111 8,842
Minority Interest (Liabilities) 0 0 0 0 0
Total Liabilities 39,157 39,240 38,997 39,545 37,448
Shareholders Equity 9/30/2021 6/30/2021 3/31/2021 12/31/2020 9/30/2020
Preferred Stock 0 0 0 0 0
Common Stock (Par) 24,285 24,153 24,023 24,145 24,037
Capital Surplus 0 0 0 0 0
Retained Earnings 30,376 29,053 28,669 27,627 26,266
Other Equity -9,024 -8,837 -9,059 -8,727 -8,835
Treasury Stock 10,999 10,340 9,845 10,042 9,873
Total Shareholder's Equity 34,638 34,029 33,788 33,003 31,595
Total Liabilities & Shareholder's Equity 73,795 73,269 72,785 72,548 69,043
Total Common Equity 34,638 34,029 33,788 33,003 31,595
Shares Outstanding 1,768.20 1,772.80 1,776.80 1,772.30 1,772.30
Book Value Per Share 19.59 19.20 19.02 18.62 17.83